1,4-Diiodotetrafluorobenzene CAS 392-57-4: A Key Fluorinated Intermediate for Advanced Chemical Synthesis
Unlock cutting-edge research and development with this vital fluorinated organic building block.
Get a Quote & SampleProduct Core Value
1,4-Diiodotetrafluorobenzene
1,4-Diiodotetrafluorobenzene (CAS 392-57-4) is an indispensable fluorinated organic building block, critical for the advancement of modern chemical synthesis. Its unique structure and reactivity make it a sought-after intermediate for complex molecular architectures.
- As a crucial 1,4-diiodotetrafluorobenzene chemical intermediate, it facilitates the synthesis of complex organic molecules.
- This CAS 392-57-4 organic building block is essential for developing novel fluorinated aromatic compound synthesis.
- Its utility as an OLED material precursor aids in the creation of next-generation electronic devices.
- The compound's role as a pharmaceutical intermediate applications accelerates drug discovery and development.
Product Advantages
Enhanced Reactivity
Leverage the power of halogen bonding donor chemical properties for precise molecular assembly, enabling intricate reaction pathways.
High Purity Assurance
Benefit from a purity of 97% min, ensuring reliable and reproducible results in your synthesis of advanced materials.
Versatile Applications
This versatile compound serves across multiple domains, from materials science innovation to the meticulous demands of pharmaceutical research.
Key Applications
Organic Synthesis
Utilize 1,4-diiodotetrafluorobenzene in various organic synthesis reactions, leveraging its structure for creating novel compounds and materials.
Materials Science
Explore its potential in materials science, particularly in the development of organic electronics and functional materials, for improved performance and properties.
OLED Technology
As an OLED material precursor, it contributes to the efficiency and quality of organic light-emitting diodes, driving innovation in display technology.
Pharmaceutical Research
Its role in pharmaceutical intermediate applications supports the discovery and synthesis of new therapeutic agents and drug candidates.